ArticleMolecular and clinical oncology2013

Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases.

Yoshiko Okita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.